Concepedia

Matthew L. Goodwin

ML

Statistics

Publications

4

Citations

183

H-Index

4

Active since

2011

Affiliations

Duke Medical Center(Current)

Brown Foundation

The University of Texas at Austin

Merck & Co., Inc., Rahway, NJ, USA (United States)

Matthew L. Goodwin is an author at Duke Medical Center specializing in infectious diseases, immunology, and vaccination.

ORCID

Publications per year

2011–2020

4

Publications

4

Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization

Cody S. Nelson, Jennifer A. Jenks, Norbert Pardi et al. · Journal of Virology · 2020 · 63 citations · Full text

, , +17

Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans

Jennifer A. Jenks, Cody S. Nelson, Hunter Roark et al. · Science Translational Medicine · 2020 · 54 citations · Full text

, , +10

The Effect of HIV and HPV Coinfection on Cervical COX-2 Expression and Systemic Prostaglandin E2 Levels

Daniel W. Fitzgerald, Karl Bezak, Oksana Ocheretina et al. · Cancer Prevention Research · 2011 · 45 citations · Full text

, , +13

Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection

Matthew L. Goodwin, Helen Webster, Hsuan-Yuan Wang et al. · Virology · 2020 · 21 citations · Full text

, , +14

1–4 of 4